The Association between Thyroid-Stimulating Hormone and Long-Term Outcomes in Patients with ST Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention

References

• Razvi S, Jabbar A, Pingitore A, et al. Thyroid hormones and cardiovascular function and diseases. J Am Coll Cardiol. 2018;71(16):1781–1796. doi:10.1016/j.jacc.2018.02.045
   PubMed Web of Science ®Google Scholar
• Taylor PN, Razvi S, Pearce SH, Dayan CM. Clinical review: a review of the clinical consequences of variation in thyroid function within the reference range. J Clin Endocrinol Metab. 2013;98(9):3562–3571. doi:10.1210/jc.2013-1315
   PubMed Web of Science ®Google Scholar
• Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14(1):39–55.
   PubMed Web of Science ®Google Scholar
• Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725–1735. doi:10.1161/CIRCULATIONAHA.106.678326
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Razvi S. Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers. Lancet Diabetes Endocrinol. 2019;7(6):473–483. doi:10.1016/S2213-8587(18)30371-1
   PubMed Web of Science ®Google Scholar
• Soeiro AM, Araujo VA, Vella JP, et al. Is there any relationship between TSH levels and prognosis in acute coronary syndrome? Arq Bras Cardiol. 2018;110(2):113–118.
   PubMed Web of Science ®Google Scholar
• Seo SM, Koh YS, Park HJ, et al. Thyroid stimulating hormone elevation as a predictor of long-term mortality in patients with acute myocardial infarction. Clin Cardiol. 2018;41(10):1367–1373. doi:10.1002/clc.23062
   PubMed Web of Science ®Google Scholar
• Jabbar A, Ingoe L, Thomas H, et al. Prevalence, predictors and outcomes of thyroid dysfunction in patients with acute myocardial infarction: the ThyrAMI-1 study. J Endocrinol Invest. 2020;44:1209–1218.
   PubMed Web of Science ®Google Scholar
• Reindl M, Feistritzer HJ, Reinstadler SJ, et al. Thyroid-stimulating hormone and adverse left ventricular remodeling following ST-segment elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2019;8(8):717–726. doi:10.1177/2048872618770600
   PubMed Web of Science ®Google Scholar
• Kannan L, Shaw PA, Morley MP, et al. Thyroid dysfunction in heart failure and cardiovascular outcomes. Circ Heart Fail. 2018;11(12):e005266. doi:10.1161/CIRCHEARTFAILURE.118.005266
   PubMed Web of Science ®Google Scholar
• Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355–382. doi:10.1152/physrev.00030.2013
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary Intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016;133(11):1135–1147.
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kang T, Kang MJ, Ahn HS, Sohn SY. Incidence and mortality of myocardial infarction and stroke in patients with hyperthyroidism: a nationwide cohort study in Korea. Thyroid. 2020;30(7):955–965. doi:10.1089/thy.2019.0543
   PubMed Web of Science ®Google Scholar
• Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003;88(6):2438–2444. doi:10.1210/jc.2003-030398
   PubMed Web of Science ®Google Scholar
• Auer J, Berent R, Weber T, Lassnig E, Eber B. Thyroid function is associated with presence and severity of coronary atherosclerosis. Clin Cardiol. 2003;26(12):569–573. doi:10.1002/clc.4960261205
   PubMed Web of Science ®Google Scholar
• Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172(10):799–809. doi:10.1001/archinternmed.2012.402
   PubMedGoogle Scholar
• Dorr M, Robinson DM, Wallaschofski H, et al. Low serum thyrotropin is associated with high plasma fibrinogen. J Clin Endocrinol Metab. 2006;91(2):530–534. doi:10.1210/jc.2005-1786
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang N, Cai Y, Shi J. Evaluation of left ventricular diastolic function using tissue Doppler echocardiography and conventional Doppler echocardiography in patients with subclinical hypothyroidism aged <60 years: a meta-analysis. J Cardiol. 2013;61(1):8–15.
   PubMed Web of Science ®Google Scholar
• Owen PJ, Sabit R, Lazarus JH. Thyroid disease and vascular function. Thyroid. 2007;17(6):519–524. doi:10.1089/thy.2007.0051
   PubMed Web of Science ®Google Scholar
• Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365–1374. doi:10.1001/jama.2010.1361
   PubMed Web of Science ®Google Scholar
• Jose F, Goulart AC, Sommer Bittencourt M, et al. Relationship between TSH levels and the advanced lipoprotein profile in the Brazilian longitudinal study of adult health (ELSA-Brasil). Endocr Res. 2020;45(3):163–173. doi:10.1080/07435800.2020.1721013
   PubMed Web of Science ®Google Scholar
• Karbownik-Lewinska M, Stepniak J, Zurawska A, Lewinski A. Less favorable lipid profile and higher prevalence of thyroid antibodies in women of reproductive age with high-norMAL TSH-retrospective study. Int J Environ Res Public Health. 2020;17(6):2122. doi:10.3390/ijerph17062122
   PubMed Web of Science ®Google Scholar
• Li H, Cui Y, Zhu Y, Yan H, Xu W. Association of high normal HbA1c and TSH levels with the risk of CHD: a 10-year cohort study and SVM analysis. Sci Rep. 2017;7:45406. doi:10.1038/srep45406
   PubMed Web of Science ®Google Scholar
• Ruggeri RM, Trimarchi F, Biondi B. Management of endocrine disease: l-Thyroxine replacement therapy in the frail elderly: a challenge in clinical practice. Eur J Endocrinol. 2017;177(4):R199–R217. doi:10.1530/EJE-17-0321
   PubMed Web of Science ®Google Scholar
• José F Peixoto de Miranda E, Mastorci F, Piaggi P, et al. Usefulness of triiodothyronine replacement therapy in patients with ST elevation myocardial infarction and borderline/reduced triiodothyronine levels (from the THIRST study). Am J Cardiol. 2019;123(6):905–912. doi:10.1016/j.amjcard.2018.12.020
   PubMed Web of Science ®Google Scholar
• Jabbar A, Ingoe L, Junejo S, et al. Effect of levothyroxine on left ventricular ejection fraction in patients with subclinical hypothyroidism and acute myocardial infarction: a randomized clinical trial. JAMA. 2020;324(3):249–258. doi:10.1001/jama.2020.9389
   PubMed Web of Science ®Google Scholar